Crinetics Pharmaceuticals, Inc. - COM (CRNX)

Historical Portfolio Holders from Q3 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
84.5M
Holdings value Q3 2024
$4.32B
Value change Q3 2024
+$33.6M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
230
Number of buys Q3 2024
119
Number of sells Q3 2024
-98
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 84.5M $4.32B +$33.6M $51.10 230
2024 Q2 82.5M $3.69B +$92M $44.79 232
2024 Q1 80.4M $3.76B +$486M $46.81 202
2023 Q4 70.7M $2.51B +$69M $35.58 181
2023 Q3 68.5M $2.04B +$441M $29.74 173
2023 Q2 54M $973M -$11.9M $18.02 137
2023 Q1 55M $884M +$1.99M $16.06 126
2022 Q4 54.8M $1B -$14.2M $18.30 119
2022 Q3 51.4M $1.01B +$15.5M $19.64 116
2022 Q2 50.6M $945M +$94.8M $18.65 110
2022 Q1 45.5M $997M -$15.3M $21.95 113
2021 Q4 44.3M $1.26B +$252M $28.41 114
2021 Q3 33.6M $708M +$17.2M $21.05 91
2021 Q2 32.7M $617M +$42.4M $18.85 81
2021 Q1 30.7M $465M +$5.52M $15.28 78
2020 Q4 30.4M $429M -$4.59M $14.11 84
2020 Q3 30.3M $475M -$19.9M $15.67 70
2020 Q2 31.5M $546M +$189M $17.52 79
2020 Q1 20.7M $304M +$45.4M $14.70 55
2019 Q4 17.5M $440M -$5.48M $25.09 58
2019 Q3 15.2M $229M -$94.3M $15.04 60
2019 Q2 18.9M $473M +$31.1M $25.00 63
2019 Q1 17.7M $404M +$20.7M $22.76 62
2018 Q4 16.8M $503M +$19M $29.99 50
2018 Q3 16.2M $463M +$463M $28.65 49